Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Epizyme Inc (NQ: EPZM )

12.25 USD UNCHANGED
Streaming Delayed Price Updated: 5:29 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Epizyme Inc

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Relative Strength Alert For Epizyme
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Epizyme Announces Date of Second Quarter 2020 Financial Results and Participation at 2020 Wedbush PacGrow Healthcare Virtual Conference
Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, today announced that management will host a conference... 
From Business Wire News Releases
Analysts Predict 13% Upside For IBB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Stocks Showing Improved Relative Strength: Epizyme
Epizyme shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Epizyme Shows Rising Relative Strength; Still Shy Of Key Threshold
Epizyme shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
Top Buys by Directors: Mott's $994.2K Bet on EPZM
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... 
Tags Stocks
From Market News Video
Monday 6/29 Insider Buying Report: BSIG, EPZM
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. 
Tags Stocks
From Market News Video
Notable Insider Buys: Continental Resources, Fox, Groupon And More
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit. So insider buying can be an... 
Tags Utilities Energy Stocks / Equities
From Blogs - TalkMarkets
Notable Insider Buys: Continental Resources, Fox, Groupon And More
Insider buying can be an encouraging signal for potential investors. Some C-suite insiders were among those recently adding to ... 
Tags GRPN ED Insider Trades
From Benzinga
Stocks Flashing Renewed Technical Strength: Epizyme
Epizyme shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 74 to 81. 
From Investor's Business Daily
75 Biggest Movers From Friday
Gainers Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) shares rose 95% to close at $39.00 on Friday after the company priced its ... 
Tags KRMD HUD BYSI
From Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Gainers Broadway Financial Corporation (NASDAQ: BYFC) shares jumped 199% to $5.08. Cohen & Company Inc (NYSE: COHN) shares ... 
Tags PGEN Movers BBGI
From Benzinga
Epizyme's Tazverik Wins FDA Approval to Treat Follicular Lymphoma
The label expansion for the drug significantly increases the number of patients to whom it can be prescribed. 
Tags EPZM Market News
From Motley Fool
Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for Relapsed/Refractory Follicular Lymphoma
Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for Relapsed/Refractory Follicular Lymphoma 
From Business Wire News Releases
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ODT RHHBY LPTX
From Benzinga
Analysts Anticipate FYX To Hit $62
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
2 Top Cancer Treatment Stocks to Buy in June
If you have cash to spare, these cancer stocks are set to soar. 
Tags STAA MRSN PFE
From Motley Fool
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke, And Ultragenyx
Biotech stocks came under pressure along with the broader market in the week that ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-board sell-off in... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke And Ultragenyx
Biotech stocks came under pressure along with the broader market in the week ended June 12, as a worsening pandemic situation and its ... 
Tags NARI UROV GILD
From Benzinga
Noteworthy Friday Option Activity: EPZM, JNJ, FDX
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Epizyme Inc. (EPZM), where a total of 5,638 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Stocks Showing Rising Market Leadership: Epizyme Earns 81 RS Rating
A Relative Strength Rating upgrade for Epizyme shows improving technical performance. 
From Investor's Business Daily
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
Despite the FDA tied up with COVID-19-related activities, May turned out to be a positive month for biopharma companies from the ... 
Tags NBRV ABBV HRTX
From Benzinga
Analysts Expect XBI Will Reach $134
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Noteworthy Thursday Option Activity: GRUB, NEM, EPZM
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in GrubHub Inc (GRUB), where a total volume of 30,678 contracts has been traded thus... 
Tags Stocks
From Market News Video
Epizyme to Present Data from Tazemetostat Clinical Program during the 2020 ASCO Virtual Scientific Program
Epizyme to Present Data from Tazemetostat Clinical Program during the 2020 ASCO Virtual Scientific Program 
From Business Wire News Releases
Epizyme Inc (EPZM) Q1 2020 Earnings Call Transcript
EPZM earnings call for the period ending March 31, 2020. 
Tags EPZM Market News
From Motley Fool
Epizyme: Q1 Earnings Insights
Shares of Epizyme (NASDAQ:EPZM) were unaffected at $15.75 after the company reported Q1 results. Quarterly ... 
Tags News Market News EPZM
From Benzinga
Epizyme Reports Business Progress and First Quarter 2020 Financial Results
Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing novel epigenetic therapies, today provided business and pipeline updates and reported first quarter... 
From Business Wire News Releases
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags PCRX PFNX EDIT
From Benzinga
Epizyme Announces Date of First Quarter 2020 Financial Results
Epizyme, Inc. (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing novel epigenetic therapies, today announced that management will host a conference call and... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account